Can we determine the mechanism behind cancer risk reduction with glucagon-like peptide-1 receptor agonists (GLP-1RAs)? Meeting Abstract

publication date

  • June 1, 2025

webpage

published in

start page

  • 10535

end page

  • 10535

volume

  • 43

issue

  • 16_SUPPL